Our findings are in line with reports of enhanced ADGRG3 transcription in PMNs of patients with severe trauma injury (39) as well as in blood cells of Parkinson's disease and type 2 diabetes patients (40). This evidence concerns the gene ADGRG3 and Parkinson disease.